Synonyms: ADR-529 | Cardioxane® | ICRF-187 | Savene® | Zinecard®
dexrazoxane is an approved drug (FDA (1995), EMA (2006))
Compound class:
Synthetic organic
Comment: Dexrazoxane is an EDTA derivative with iron-chelating activity.
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (1995), EMA (2006)) |
IUPAC Name |
6-hydroxy-4-[(2S)-2-(5-hydroxy-3-oxo-1,2,3,6-tetrahydropyrazin-1-yl)propyl]-2,3,4,5-tetrahydropyrazin-2-one |
International Nonproprietary Names | |
INN number | INN |
6544 | dexrazoxane |
Synonyms |
ADR-529 | Cardioxane® | ICRF-187 | Savene® | Zinecard® |
Database Links | |
CAS Registry No. | 24584-09-6 |
ChEMBL Ligand | CHEMBL1738 |
DrugBank Ligand | DB00380 |
DrugCentral Ligand | 839 |
GtoPdb PubChem SID | 178103902 |
PubChem CID | 71384 |
Search Google for chemical match using the InChIKey | BMKDZUISNHGIBY-ZETCQYMHSA-N |
Search Google for chemicals with the same backbone | BMKDZUISNHGIBY |
Search PubMed clinical trials | dexrazoxane |
Search PubMed titles | dexrazoxane |
Search PubMed titles/abstracts | dexrazoxane |
UniChem Compound Search for chemical match using the InChIKey | BMKDZUISNHGIBY-ZETCQYMHSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | BMKDZUISNHGIBY-ZETCQYMHSA-N |
Wikipedia | Dexrazoxane |